SCHEMBL20182289

SCHEMBL20182289

CCC(/C(=C/Nc1ccc(F)cc1F)N=N)n1cc(-c2cc(F)cnc2OC)c2c(N)ncnc21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NTRK1 P04629 2/20 0.36
NTRK3 Q16288 1/20 0.36
NTRK2 Q16620 1/20 0.36
EIF2AK3 Q9NZJ5 3/20 0.34
KDR P35968 3/20 0.33
NEK7 Q8TDX7 2/20 0.33
FLT3 P36888 3/20 0.32
EGFR P00533 3/20 0.32
ABL1 P00519 2/20 0.32
ABL2 P42684 2/20 0.32
KCNH2 Q12809 1/20 0.32
AXL P30530 1/20 0.31
SRC P12931 1/20 0.31
PIK3CG P48736 2/20 0.31
PI4KA P42356 1/20 0.31
TEK Q02763 1/20 0.31
PIK3CD O00329 1/20 0.31
PIK3CA P42336 1/20 0.31
PIK3CB P42338 1/20 0.31
PRKDC P78527 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20182235 0.94 EIF2AK3 (0.34) NTRK1NTRK3NTRK2EIF2AK3KDR
SCHEMBL20182194 0.94 EIF2AK3 (0.36) EIF2AK3KDREGFRABL1ABL2
SCHEMBL20182265 0.92 NTRK1 (0.36) NTRK1NTRK3NTRK2EIF2AK3KDR
SCHEMBL20182292 0.92 NEK7 (0.37) NTRK1NTRK3NTRK2EIF2AK3KDR
SCHEMBL20182222 0.89 AXL (0.34) EIF2AK3KDRFLT3EGFRABL1
SCHEMBL20182291 0.85 NTRK1 (0.38) NTRK1NTRK3NTRK2EIF2AK3KDR
SCHEMBL20182294 0.85 CFTR (0.40) NTRK1NTRK3NTRK2EIF2AK3NEK7
SCHEMBL20181916 0.84 CFTR (0.39) EIF2AK3KDREGFRABL1ABL2
SCHEMBL20182275 0.82 EGFR (0.36) EIF2AK3KDRNEK7FLT3EGFR
SCHEMBL20182191 0.82 ALK (0.34) EIF2AK3KDREGFRABL1ABL2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018094137-A1 PYRROLOPYRIMIDINES AS CFTR POTENTIATORS CYSTIC FIBROSIS FOUNDATION THERAPEUTICS INC. (US) 2018-05-24 WO disclosed